Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MAT | OMAB |
|---|---|---|
| Price | $16.05 | $94.98 |
| Change today | ▲ 5.11% | ▲ 0.84% |
| Market cap | $4.59B | $4.58B |
| Return, 3 months | +19.6% | -11.4% |
| Return, year to date | -19.1% | -10.1% |
| Return, 1 year | -11.2% | -1.6% |
| P/E (TTM) | 12.0 | 15.3 |
| P/B | 2.3 | 9.1 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 5.77% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +13.0% | +23.7% |
| Analyst buy share | 60% | 50% |
| RSI (14) | 70 | 37 |
| 30-day volatility | 60.6% | 23.3% |
| Max drawdown, 1 year | -42.9% | -28.2% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
